In January 2025, Dr. Neda Aminnejad from York University published, Predicting the onset of chronic kidney disease (CKD) for diabetic patients with aggregated longitudinal EMR data, in the journal PLOS Digital Health. This paper stems from a collaboration between DAC, the Fields Institute Centre for Quantitative Analysis and Modelling (Fields-CQAM), and the Vector Institute for […]

Use of SGLT-2 Inhibitors in Adults (Age 65) with Type 2 Diabetes and Cardiovascular Disease is Lower in Alberta and Manitoba than in Ontario (2018-2020): A Cross-Sectional Study of Different Drug Funding Policies. McCreary ML, Yeung RO, Manca DP, Greiver M, Singer AG, Lau D.Can J Diabetes. 2024 Sep 18:S1499-2671(24)00181-3. doi: 10.1016/j.jcjd.2024.09.003. PMID: 39303780 This study examines the lower utilization […]

In the latest issue of the Canadian Journal of Diabetes, Diabetes Action Canada’s Digital Health team published an editorial looking at the ways that technology can improve diabetes care. The publication, The Intersection of Informatics and Diabetes: Harnessing Technology to Improve Care, is an important reminder that digital solutions are being adopted quickly and can […]

In September, a team of researchers led by Dr. Alison Paprica from the Institute for Health Policy, Management and Evaluation at the Dalla Lana School of Public Health in Toronto, and Diabetes Action Canada’s Conrad Pow and Dr Michelle Greiver, published a new paper in the International Journal of Population Data Science. The publication, Essential […]

Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record Data.        Weisman A, Brown R, Chu L, Aronson R, Perkins BA.Can J Diabetes. 2024 Feb;48(1):44-52.e5. doi: 10.1016/j.jcjd.2023.09.001. Epub 2023 Sep 16.PMID: 37717631 This article explores factors associated […]

Diabetes care among individuals with and without schizophrenia in three Canadian provinces: A retrospective cohort study. O’Neill B, Yusuf A, Kurdyak P, Kiran T, Sullivan F, Chen T, Kalia S, Eisen D, Anderson E, Selby P, Campbell D.Gen Hosp Psychiatry. 2023 May-Jun;82:19-25. doi: 10.1016/j.genhosppsych.2023.02.007. Epub 2023 Mar 5. This study explores the mental health challenges […]

To save the vision of persons with diabetes Canada needs data-informed timely screening. Rac VE, Whiteside C, Bowen JM, Maberley D, Brent MH.Can J Ophthalmol. 2023 Oct;58(5):e228-e229. doi: 10.1016/j.jcjo.2023.04.001. Epub 2023 May 2.PMID: 37141921 This article examines the accessibility and utilization of vision care services, particularly for marginalized and vulnerable communities living with diabetes, highlighting disparities […]

New Diabetes Guidelines: Impact on Eligibility for Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Canada Rebecca Bodoarca, MD ∙ Roseanne O. Yeung, MD, MPH ∙ Darren Lau, MD, PhD, FRCPC  Volume 46, Issue 7 p691-698October 2022 This article reviews the impact of new diabetes treatment guidelines on the eligibility for sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in Canada, assessing how […]

By Krista Lamb New research led by Dr. Darren Lau at the University of Alberta uses data from Diabetes Action Canada’s National Diabetes Repository to look at whether people with type 2 diabetes should have access to newer drug therapies. The results of this study have been published in the Canadian Journal of Diabetes. “There […]